German Pharma Stock News

1&1 (XTRA:1U1) grabbed investor focus after its latest update. The company announced nine-month 2025 results showing a drop in net income compared to last year, yet reaffirmed expectations for stable full-year revenue and earnings. See our latest analysis for 1&1. While the nine-month results put a spotlight on lower net income, what really caught investors' attention was 1&1's decision to hold its full-year 2025 guidance steady. Despite the short-term profit dip, the share price has surged...

Deloitte’s recent adoption of SAP Joule for Consultants highlights how SAP (XTRA:SAP) is increasing its commitment to AI-powered platforms to provide real productivity gains for enterprise clients. This news, together with SAP’s broader AI enhancements and ecosystem expansions featured at SAP TechEd 2025, demonstrates the company’s ongoing focus on AI-driven growth and innovation. See our latest analysis for SAP. SAP has delivered a flurry of product launches, security fixes, and partnership...

KSB SE & Co. KGaA announced increased sales revenue of €2.23 billion and order intake of €2.45 billion for the first nine months of 2025, while reaffirming its earnings guidance for the year. This combination of top-line growth and maintained guidance signals continued operational momentum despite broader economic uncertainties. We'll assess how this steady growth in sales and orders shapes KSB SE & Co. KGaA's investment narrative going forward. AI is about to change healthcare. These 31...

Following the solid earnings report from Rheinmetall AG ( ETR:RHM ), the market responded by bidding up the stock...

In November 2025, European markets have been experiencing a pullback, with the pan-European STOXX Europe 600 Index declining by 1.24% amid concerns over artificial intelligence-related stock valuations. As investors navigate these fluctuating conditions, identifying stocks that may be trading below their fair value can present potential opportunities for those looking to capitalize on market inefficiencies and long-term growth prospects.

It's been a good week for Fraport AG ( ETR:FRA ) shareholders, because the company has just released its latest...

It's nice to see the Medios AG ( ETR:ILM1 ) share price up 21% in a week. But over the last half decade, the stock has...

It might be of some concern to shareholders to see the SUSS MicroTec SE ( ETR:SMHN ) share price down 11% in the last...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is...

Heidelberger Druckmaschinen (ETR:HDD) has had a great run on the share market with its stock up by a significant 14...

Key Insights HORNBACH Holding KGaA's estimated fair value is €107 based on 2 Stage Free Cash Flow to Equity With €85.80...

Hensoldt AG's ( ETR:HAG ) stock was strong after they recently reported robust earnings. However, we think that...

Ernst Russ AG ( ETR:HXCK ) just released its latest quarterly results and things are looking bullish. It was overall a...

Basler Aktiengesellschaft ( ETR:BSL ) just reported healthy earnings but the stock price didn't move much. We think...

It's been a pretty great week for Bayer Aktiengesellschaft ( ETR:BAYN ) shareholders, with its shares surging 13% to...

The NAGA Group AG ( ETR:N4G ) is possibly approaching a major achievement in its business, so we would like to shine...

PVA TePla AG ( ETR:TPE ) shareholders won't be pleased to see that the share price has had a very rough month, dropping...

MAX Automation SE's ( ETR:MXHN ) stock didn't jump after it announced some healthy earnings. We did some digging and...

The market for Deutsche Post AG's ( ETR:DHL ) stock was strong after it released a healthy earnings report last week...

Key Insights Gesco's significant retail investors ownership suggests that the key decisions are influenced by...

Ströer SE & Co. KGaA ( ETR:SAX ) shareholders are probably feeling a little disappointed, since its shares fell 3.6% to...

A lackluster earnings announcement from DEUTZ Aktiengesellschaft ( ETR:DEZ ) last week didn't sink the stock price. Our...

Merck KGaA recently reported third-quarter 2025 results, delivering sales of €5.32 billion and net income of €902 million, both modestly higher than the previous year. This performance was boosted by legislative changes in South America, the sale of a U.S. priority review voucher, and revenue contributions from recently acquired rare cancer treatments. We’ll assess how the outperformance in operating earnings and maintained guidance influences Merck KGaA’s investment narrative and future...

Vonovia (XTRA:VNA) is drawing renewed attention after announcing a sharp turnaround in its quarterly and nine-month results. The company has also introduced several new bond offerings and completed successful refinancing moves this November. See our latest analysis for Vonovia. With shares recently closing at €26.29, Vonovia’s latest slew of refinancing initiatives and a dramatic return to quarterly profitability have started to steady investor nerves, even as the year-to-date share price...